This company has been marked as potentially delisted and may not be actively trading. Vallon Pharmaceuticals (VLON) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VLON vs. CPIX, PYXS, VERU, PDSB, IMAB, MIST, IGMS, ADAG, EPIX, and UNCYShould you be buying Vallon Pharmaceuticals stock or one of its competitors? The main competitors of Vallon Pharmaceuticals include Cumberland Pharmaceuticals (CPIX), Pyxis Oncology (PYXS), Veru (VERU), PDS Biotechnology (PDSB), I-Mab (IMAB), Milestone Pharmaceuticals (MIST), IGM Biosciences (IGMS), Adagene (ADAG), ESSA Pharma (EPIX), and Unicycive Therapeutics (UNCY). These companies are all part of the "pharmaceutical preparations" industry. Vallon Pharmaceuticals vs. Cumberland Pharmaceuticals Pyxis Oncology Veru PDS Biotechnology I-Mab Milestone Pharmaceuticals IGM Biosciences Adagene ESSA Pharma Unicycive Therapeutics Vallon Pharmaceuticals (NASDAQ:VLON) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability. Which has stronger earnings and valuation, VLON or CPIX? Cumberland Pharmaceuticals has higher revenue and earnings than Vallon Pharmaceuticals. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Vallon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVallon Pharmaceuticals$100K161.78-$7.02M-$0.78-1.54Cumberland Pharmaceuticals$41.08M1.85-$6.28M-$0.25-20.32 Does the MarketBeat Community prefer VLON or CPIX? Cumberland Pharmaceuticals received 188 more outperform votes than Vallon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Vallon Pharmaceuticals an outperform vote while only 41.81% of users gave Cumberland Pharmaceuticals an outperform vote. CompanyUnderperformOutperformVallon PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesCumberland PharmaceuticalsOutperform Votes18941.81% Underperform Votes26358.19% Do institutionals and insiders have more ownership in VLON or CPIX? 8.7% of Vallon Pharmaceuticals shares are held by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. 37.3% of Vallon Pharmaceuticals shares are held by company insiders. Comparatively, 44.8% of Cumberland Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, VLON or CPIX? Vallon Pharmaceuticals has a beta of -1.14, indicating that its stock price is 214% less volatile than the S&P 500. Comparatively, Cumberland Pharmaceuticals has a beta of -0.35, indicating that its stock price is 135% less volatile than the S&P 500. Does the media prefer VLON or CPIX? In the previous week, Cumberland Pharmaceuticals had 1 more articles in the media than Vallon Pharmaceuticals. MarketBeat recorded 1 mentions for Cumberland Pharmaceuticals and 0 mentions for Vallon Pharmaceuticals. Vallon Pharmaceuticals' average media sentiment score of 0.00 equaled Cumberland Pharmaceuticals'average media sentiment score. Company Overall Sentiment Vallon Pharmaceuticals Neutral Cumberland Pharmaceuticals Neutral Is VLON or CPIX more profitable? Vallon Pharmaceuticals has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -29.54%. Cumberland Pharmaceuticals' return on equity of -9.50% beat Vallon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Vallon PharmaceuticalsN/A -230.48% -124.89% Cumberland Pharmaceuticals -29.54%-9.50%-3.19% SummaryCumberland Pharmaceuticals beats Vallon Pharmaceuticals on 10 of the 14 factors compared between the two stocks. Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLON vs. The Competition Export to ExcelMetricVallon PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.18M$6.46B$5.34B$8.30BDividend YieldN/A2.63%5.27%4.11%P/E Ratio-1.548.4426.9619.59Price / Sales161.78258.50398.81136.01Price / CashN/A65.8538.3234.64Price / Book6.676.416.774.50Net Income-$7.02M$143.95M$3.24B$248.60M Vallon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLONVallon PharmaceuticalsN/A$1.20-4.0%N/A+175.3%$16.18M$100,000.00-1.543Gap DownCPIXCumberland Pharmaceuticals0.493 of 5 stars$5.03-7.7%N/A+221.5%$75.25M$41.08M-6.5380PYXSPyxis Oncology1.5468 of 5 stars$1.21-1.6%$9.00+643.8%-67.8%$74.96M$16.15M-1.1760News CoverageAnalyst RevisionVERUVeru1.4445 of 5 stars$0.51-1.9%$4.00+684.5%-60.7%$74.74M$16.89M-1.96230PDSBPDS Biotechnology1.574 of 5 stars$1.63+11.6%$9.00+452.1%-49.4%$74.51MN/A-1.4120News CoverageAnalyst UpgradeAnalyst RevisionGap UpHigh Trading VolumeIMABI-Mab2.962 of 5 stars$0.91+0.3%$5.50+502.0%-43.4%$74.46M$3.27M0.00380MISTMilestone Pharmaceuticals2.8265 of 5 stars$1.39+7.8%$17.00+1,123.0%-12.0%$74.32M$1M-1.7230News CoveragePositive NewsIGMSIGM Biosciences4.2581 of 5 stars$1.24flat$5.50+343.5%-87.6%$74.12M$2.68M-0.34190Positive NewsGap UpADAGAdagene2.0261 of 5 stars$1.56-11.9%$8.00+412.8%-34.8%$73.49M$103,204.000.00260News CoverageGap DownEPIXESSA Pharma1.9767 of 5 stars$1.65-2.9%$2.00+21.2%-73.2%$73.24MN/A-2.3950Positive NewsUNCYUnicycive Therapeutics3.2083 of 5 stars$0.60-1.0%$5.50+816.7%-42.9%$73.10M$680,000.00-0.629Positive News Related Companies and Tools Related Companies CPIX Alternatives PYXS Alternatives VERU Alternatives PDSB Alternatives IMAB Alternatives MIST Alternatives IGMS Alternatives ADAG Alternatives EPIX Alternatives UNCY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VLON) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vallon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vallon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VLON Stock Free VLON Stock Alerts